Women with breast cancer who take anti-estrogen supplements may be decreasing their risk for melanoma as well, Swiss researchers suggest. Dr. Christine Bouchardy, a professor at the University of Geneva and head of the Geneva Cancer Registry, and colleagues analyzed data from 7,360 women who had breast cancer from 1980 to 2005. Fifty-four percent of the women received anti-estrogen therapy. The researchers tracked the patients until 2008 and recorded 34 melanoma cases during the follow-up period. The study, published in Cancer Prevention Research, found the risk for melanoma was 60 percent higher among patients who did not receive anti-estrogen therapy, compared with patients who received anti-estrogen therapy. "The data reinforce the hypothesis that estrogens play a role in melanoma occurrence," Bouchardy said in a statement. Bouchardy cautioned against widespread anti-estrogen supplementation to prevent melanoma in the general population. "These results need to be replicated in other studies, particularly given the numerous side effects linked to this kind of drug," Bouchardy said.
GMT 13:50 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 13:20 2018 Monday ,29 October
National campaign to raise awareness of breast cancerGMT 14:34 2018 Friday ,19 October
Birth spacing "improving health of Omani women"GMT 15:35 2018 Thursday ,11 October
Russia to discuss issue of biological labs near its bordersGMT 16:14 2018 Saturday ,29 September
Premier Khalifa bin Salman congratulated by health ministerGMT 16:10 2018 Saturday ,29 September
Bahrain to host Dermatology, Laser and Aesthetics ConferenceGMT 12:44 2018 Friday ,28 September
EU proposes €40 million for UNRWA to keep health clinics openGMT 07:46 2018 Wednesday ,26 September
HRH Premier to address UN high-level health meetingsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor